PhD Student, Department of Psychology, University of Victoria Cole J. Kennedy is a Doctoral student of Clinical Neuropsychology in the Department of Psychology at the University of Victoria. He is a Student Senator, a member of the CORTEX lab, a Student Affiliate of the Institute on Aging & Lifelong Health, and is the Graduate Student Research Lead for the BC Consensus on Brain Injury. Additionally, Cole is the Founder, Lead Researcher & Project Manager of DECISION–MAP (Database of Evidence Concerning Interventions Supporting the Intersections Of Neurotrauma–Mental health, & Addictions Problems). Inspired by his clinical experiences supporting survivors of brain injury in the community, Cole’s previous research examined the clinical sequalae and management of sport-related concussion in elite athletes, whereas his more recent research aims to better the lives of those struggling with concurrent acquired brain injury, psychiatric disorders, and substance use/addictions through a variety of community-engaged and patient-oriented approaches.
PhD Candidate, Faculty of Information, University of Toronto Cate Cleo Alexander (she/her) is a PhD Candidate in the Faculty of Information at the University of Toronto. Prior to U of T, Cate obtained a BA Combined Honours in History and Classics and a MA in Digital Humanities at the University of Alberta. Her lifelong passion for history has taken her from archaeological field digs in Greece and Italy to the digital realms of online archives. Cate's doctoral research examines digital public history through affect and political economic theory in order to establish a better understanding of how platforms influence the production, distribution, and consumption of public history. Cate's research was generously supported by SSHRC in both her Masters' and her PhD, and she is the coordinator for the GLAM Incubator at the University of Toronto.
Senior Research Fellow in the Institute of Population Health, NIHR Applied Research Collaboration North West Coast, University of Liverpool My research focuses on Inequalities in Dementia and ageing in the UK, across Europe, in Australia, and in lower and middle-income countries. Patient, public, and stakeholder involvement is at the core of all my work, to shape, conduct, and disseminate research with the expertise of people with lived, care professional, and third sector experiences. My research group at the University of Liverpool works with the public to co-produce solutions to inequities in dementia diagnosis and care.
Associate Professor of Psychology, University of Southampton My research is located in the area of quantitative social/personality psychology. In particular, I conduct research on narcissistic dysfunction in the interpersonal domain. I am currently involved in projects investigating: the self-presentation of narcissists; nostalgia; narcissism and social support; narcissism and empathy; narcissism and mimicry; narcissism and bullying; narcissism and prosocial behaviours; narcissism and crime; narcissism and parenting; narcissism and consumerism; narcissism and team functioning; narcissism and romantic relationships
Professor of Gene Therapy and Paediatric Immunology, UCL Claire is Professor of paediatric immunology and gene therapy at UCL Great Ormond Street Hospital Institute of Child Health in London and leads the clinical stem cell gene therapy programme at Great Ormond Street Hospital. She is a clinical academic leading an expanding number of gene therapy clinical trials for patients with immune deficiencies, haematological and metabolic disorders. Her research is focused on developing novel therapies for immune system disorders using innovative gene modification techniques. She has extensive experience of translating, leading, and delivering first in human clinical trials and the commercialisation pathway. As an attending physician she oversees the clinical management of patients with immune deficiencies, including hematopoietic stem cell transplantation and maintains a strong interest in HLH disorders. Claire is an elected board member of the European and American Societies of Gene and Cell Therapy, serves on the editorial board of several journals and grant review committees and holds an honorary position at Boston Children’s Hospital and Harvard Medical School. She is also the co-founder of the AGORA initiative (Access to Gene therapies fOr Rare disease) which brings together European academic developers and patient organisations, aiming to facilitate access to effective gene therapies for treatment of patients with ultra-rare diseases.
